Astec LifeSciences Limited has informed the Exchange that Board of Directors at its meeting held on June 30, 2025, has decided to issue Equity shares on rights basis in the ratio of 1 : 7, i.e 1 Equity Share for every 7 Equity Shares held. Issue Price is Rs. 890 per share.
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 2.8 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Astec LifeSciences Limited's board has approved a rights issue to raise up to Rs. 249.35 crore. The company will issue 28,01,673 equity shares at Rs. 890 per share (including a premium of Rs. 880) in the ratio of 1:7, meaning 1 new share for every 7 shares held. The record date to determine eligible shareholders is July 4, 2025, with the issue opening on July 14 and closing on July 28, 2025. Post-issue, the total share count will rise from 1.96 crore to 2.24 crore, assuming full subscription.
The rights issue will dilute existing shareholdings by about 14.3% if fully subscribed. Shareholders as of the record date must decide whether to invest additional capital to retain their proportional ownership or let entitlements lapse, which could create short-term pressure on the stock price.